Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Times Denmark.
Menstrual Cup Market to Reach USD 2.5B by 2032, Eco-Friendly Reusable Cups, Smart Designs & Sustainable Hygiene Trends
The global menstrual cup market is expanding rapidly, due to growing environmental awareness and cost-effectiveness. WILMINGTON, DE, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- Explore the booming Menstrual Cup Market, valued at USD...
Chia Seeds Market Set to Witness Significant Growth by 2025-2032 | Nutiva Inc., Organic Denmark, Hodmedod, The Chia Co
BURLINGAME, CA, UNITED STATES, February 17, 2025 /EINPresswire.com/ -- The Chia Seed Market is estimated to be valued at USD 1.72 Bn in 2025 and is expected to reach USD 4.13 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.3%...
ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX® for the treatment of persistent, moderate to severe house dust mite allergic rhinitis in...
Oracando Campaign Showcases Premium European PDO Oranges & Avocados at Copenhagen Press Event
COPENHAGEN, DENMARK, January 21, 2025 /EINPresswire.com/ -- The Producers Association of the Agricultural Cooperative of Chania, Greece, hosted a successful Press Event for the 3-year promotional campaign “Oracando” on January 16th, 2025, at 5...
Understanding the Science of Meaty Flavours Could be Key to Sustainable Diets, says Academic
Understanding the science behind meaty tastes and textures could be the key for more people switch to a planet-friendly plant diet, researchers suggest. NEW YORK, NY, UNITED STATES, January 27, 2025 /EINPresswire.com/ -- Understanding the...
BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals
News Release January 23, 2025 BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals COPENHAGEN, DENMARK, January 23, 2025 (GLOBE NEWSWIRE) – BioPorto, an in vitro diagnostics company focused...
Mesotherapy Market Set to Reach USD 0.56 Billion, with a Healthy 12.48% CAGR Till Forecasts 2032
Authenticated data presented in the mesotherapy Market report is based on findings of extensive primary and secondary research US, NY, UNITED STATES, January 27, 2025 /EINPresswire.com/ -- Market Research Future Latest Industry Insights on...
Therapeutic Drug Monitoring (TDM) Market Size Expected to Reach USD 2.80 Bn by 2034
Ottawa, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The global therapeutic drug monitoring (TDM) market size was valued at USD 1.92 billion in 2024 and is predicted to hit around USD 2.8 billion by 2034, rising at a 3.84% CAGR, a study published by Towards...
Oracando Campaign Showcases Premium European PDO Oranges & Avocados at Copenhagen Press Event
COPENHAGEN, Denmark, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The Producers Association of the Agricultural Cooperative of Chania, Greece, hosted a successful Press Event for the 3-year promotional campaign “Oracando” on January 16th 2025 at Akropolis...
IMMvention Therapeutix Enters Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo...
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of...
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
CAMPBELL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs,...
Richardson Electronics Announces Strategic Transaction for its Richardson Healthcare Business Unit
Majority of Richardson Healthcare Assets Sold to DirectMed Imaging Remaining Healthcare Business to be Consolidated into the Company’s PMT Strategic Business Unit LAFOX, Ill., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Richardson Electronics, Ltd. (NASDAQ:...
Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference
- Ascendis positioned to drive rapid revenue growth COPENHAGEN, Denmark, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2025 key corporate milestones....
Ascendis Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
COPENHAGEN, Denmark, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 11:15 a.m....
Rezilient Health and TrueClaim Partner to Improve Access to Quality and Affordable Healthcare
Rezilient Heath and TrueClaim announced the launch of their partnership to bring value-based primary care to more people via employer health benefits. ST. LOUIS, MO, UNITED STATES, January 6, 2025 /EINPresswire.com/ -- Rezilient Heath, a leading...
AAV Gene Therapy Market Size to Skyrocket at 40.1% CAGR by 2034
Ottawa, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The global AAV gene therapy market size was valued at USD 2.75 billion in 2024 and is predicted to hit around USD 78.56 billion by 2034, rising at a 40.1% CAGR, a study published by Towards Healthcare a...
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
Press Release – No. 2 / 2025 Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity Copenhagen, Denmark, January 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company...
Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to 20 novel drug programmes in obesity, type 2 diabetes, and cardiovascular disease Expanded collaboration includes near-term...